| Income Statement |
| Operating Expenses | 10.75M |
|
| Research and Development Expense | 6.40M |
| Selling, General and Administrative Expense | 4.35M |
| Operating Income | -10.75M |
| Interest Expense | 1000 |
| Net Income | -9.60M |
| Net Income Common Stock | -9.60M |
| Net Income Common Stock (USD) | -9.60M |
| Consolidated Income | -9.60M |
| Earnings per Basic Share | -0.05 |
| Earnings per Basic Share (USD) | -0.05 |
| Earnings per Diluted Share | -0.05 |
| Earning Before Interest & Taxes (EBIT) | -9.60M |
| Earning Before Interest & Taxes (USD) | -9.60M |
| Weighted Average Shares | 209.66M |
| Weighted Average Shares Diluted | 209.66M |
| Balance Sheet |
| Cash and Equivalents | 132.68M |
| Cash and Equivalents (USD) | 132.68M |
| Current Assets | 133.24M |
| Total Assets | 133.32M |
| Current Liabilities | 5.62M |
| Total Liabilities | 5.95M |
| Accumulated Retained Earnings (Deficit) | -162.32M |
| Shareholders Equity | 127.36M |
| Shareholders Equity (USD) | 127.36M |
| Assets Non-Current | 72.00K |
| Liabilities Non-Current | 333.00K |
| Trade and Non-Trade Payables | 2.70M |
| Cash Flow |
| Net Cash Flow from Financing | 3.13M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -757.00K |
| Issuance (Purchase) of Equity Shares | 3.20M |
| Issuance (Repayment) of Debt Securities | -71.00K |
| Net Cash Flow from Operations | -3.89M |
| Share Based Compensation | 4.30M |